PRTK stock forecast
Our latest prediction for Paratek Pharmaceuticals, Inc.'s stock price was made on the Oct. 3, 2019 when the stock price was at 3.84$.
In the short term (2weeks), PRTK's stock price should outperform the market by 0.08%. During that period the price should oscillate between -10.93% and +15.82%.
In the medium term (3months), PRTK's stock price should outperform the market by 1.44%. During that period the price should oscillate between -21.87% and +42.01%.
Get email alertsCreate a solid portfolio with PRTK
About Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.
At the moment the company generates 25M USD in revenues.
On its last earning announcement, the company reported a loss of -3.83$ per share.
The book value per share is 2.69$
Three months stock forecastOct. 3, 2019
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25M | 100.00% | -112M | -457.40% | -124M | -3.83 | - | - | 32M | 2.69 | -118M | - | -118M |